Is Mounjaro still on shortage?

FDA officially declared the tirzepatide shortage RESOLVED in October 2024. This triggered the 503A compounding wind-down — compounded tirzepatide must cease within 60 days of FDA shortage resolution declaration. Regional supply intermittency persists at some doses (5mg, 7.5mg are most common gaps). If your pharmacy is out, check: another local pharmacy, LillyDirect cash-pay ($549/month maintenance), telehealth compounders before their wind-down deadline. Brand Mounjaro is the most reliable supply path post-shortage.

Does Medicare cover Mounjaro? Coverage, PA, and cash-pay (2026)

About Medicare

How Medicare handles GLP-1s

Medicare Part D covers GLP-1s for type 2 diabetes (Ozempic, Mounjaro) but historically excluded weight-loss indications. The 2026 CMS rule expanded Wegovy coverage for cardiovascular risk reduction in qualifying enrollees.

Prior authorization

What Medicare requires for Mounjaro

T2D + metformin trial.

When coverage fails

Cash-pay route

No cash assistance for Medicare.

Editorial notes

Medicare T2D coverage well-established.

Other drugs on Medicare

Medicare Wegovy →
Medicare Zepbound →
Medicare Ozempic →
Medicare Saxenda →

Mounjaro on other insurers

Aetna Mounjaro →
Blue Cross Blue Shield Mounjaro →
Cigna Mounjaro →
UnitedHealthcare Mounjaro →
Humana Mounjaro →
Kaiser Permanente Mounjaro →

Editorial summary, not legal or medical advice. Insurance formularies change quarterly. Verify with your specific plan member services before relying on any single source. Copay ranges reflect typical commercial plans; your plan may differ.